missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Novus Biologicals™ KA1/GRIK4/Glutamate Receptor KA1 Antibody Blocking Peptide
Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
Brand: Novus Biologicals™ NBP1-76852PEP
Additional Details : Weight : 0.00970kg
Description
A blocking peptide containing 14 amino acids near the amino terminus of human Grik4. Source: Synthetic (Accession #: Q16099) The KA1/GRIK4/Glutamate Receptor KA1 Blocking Peptide has been validated for the following applications: Antibody Competition.Specifications
2900 | |
Store at -20 C. Avoid freeze-thaw cycles. | |
This Peptide is Useful as a Blocking Peptide for NBP1-76852. For Further Blocking Peptide Related Protocol, Click Here . | |
GRIK4 | |
0.05 mg | |
Synthetic |
Human | |
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin. | |
EAA1, Excitatory amino acid receptor 1, glutamate receptor KA1, Glutamate receptor KA-1, glutamate receptor, ionotropic kainate 4, glutamate receptor, ionotropic, kainate 4, KA1GRIK | |
KA1/GRIK4/Glutamate Receptor KA1 | |
RUO - research use only | |
14 amino acids near the amino terminus of human Grik4 |